Insider Stock Trading History of Rudnic Edward M


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Rudnic Edward M since year 2005. The trader's CIK number is 1263483. At the time of this reporting, Rudnic Edward M is the President and CEO of Advancis Pharmaceutical Corp . (stock ticker symbol AVNC). See this page for all insider trading activities at Advancis Pharmaceutical Corp .


Stock purchases, sales, and option exercises reported by insider Rudnic Edward M since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2007-11-26 MBRK Advancis Pharmaceutical Corp Sale 11,400 1.10 12,597
2007-11-20 MBRK Advancis Pharmaceutical Corp Sale 5,000 1.15 5,729
2007-11-21 MBRK Advancis Pharmaceutical Corp Sale 4,300 1.09 4,687
2007-11-23 MBRK Advancis Pharmaceutical Corp Sale 2,400 1.04 2,508
2007-11-16 MBRK Advancis Pharmaceutical Corp Sale 1,300 1.18 1,534
2007-11-15 MBRK Advancis Pharmaceutical Corp Sale 5,400 1.21 6,534
2007-11-19 MBRK Advancis Pharmaceutical Corp Sale 10,200 1.18 12,036
2007-10-18 MBRK Advancis Pharmaceutical Corp Sale 12,600 1.43 18,018
2007-10-15 MBRK Advancis Pharmaceutical Corp Sale 7,700 1.60 12,281
2007-10-16 MBRK Advancis Pharmaceutical Corp Sale 9,000 1.54 13,905
2007-10-17 MBRK Advancis Pharmaceutical Corp Sale 10,700 1.49 15,943
2007-09-17 MBRK Advancis Pharmaceutical Corp Sale 13,100 2.22 29,147
2007-09-18 MBRK Advancis Pharmaceutical Corp Sale 26,900 2.24 60,336
2007-08-23 MBRK Advancis Pharmaceutical Corp Sale 11,000 2.36 25,938
2007-08-22 MBRK Advancis Pharmaceutical Corp Sale 16,000 2.37 37,904
2007-08-24 MBRK Advancis Pharmaceutical Corp Sale 13,000 2.30 29,899
2006-11-21 AVNC Advancis Pharmaceutical Corp Sale 10,000 4.07 40,679
2006-09-20 AVNC Advancis Pharmaceutical Corp Sale 40,000 5.61 224,360
2006-02-16 AVNC Advancis Pharmaceutical Corp Option Ex 221,299 .50 111,755
2006-02-16 AVNC Advancis Pharmaceutical Corp Sale 110,000 1.83 201,410

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Rudnic Edward M (President and CEO of Advancis Pharmaceutical Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.